Two’s a Company, Three’s a Crowd: A Review of Initiating or Switching to a Two-Drug Antiretroviral Regimen in Treatment-Naïve and Treatment-Experienced Patients Living With HIV-1
Infectious Diseases and Therapy - United States
doi 10.1007/s40121-020-00290-w
Full Text
Open PDFAbstract
Available in full text
Date
March 19, 2020
Authors
Publisher
Springer Science and Business Media LLC